Cancer in AfricaAfrica and other low- and middle-income regions are collectively responsible for 70% of the global cancer burden. Africa faces a 67% mortality-to-incidence ratio from cancer according to recent statistics released by the World Health Organization’s International Agency for Research on Cancer (IARC). Compare this number to the 23% touted by Northern America, andContinue reading “Closing the Cancer Care Gap in Africa”
Category Archives: AC3T
Clinical trial training program addresses cancer data gap in Africa and enables new research ventures for African clinicians
Africa has historically been overlooked by the international oncology research community, resulting in the continent’s participation in less than 2% of all cancer clinical trials. Africa’s underrepresentation in cancer clinical trials has culminated in an alarming lack of data describing the effects of new cancer technologies and treatments in the world’s most genetically diverse population.Continue reading “Clinical trial training program addresses cancer data gap in Africa and enables new research ventures for African clinicians”
AC3T Study Pool Mini-Grants empower early-career cancer researchers
Despite representing 4% of the world’s new cancer cases in 2020, only 0.5% of cancer clinical trials have been performed in sub-Saharan Africa. Several factors, including the continent’s limited number of experienced clinical researchers, have contributed to Africa’s underrepresentation in clinical trials. Given the continent’s predicted increase in new cancer cases over the next twoContinue reading “AC3T Study Pool Mini-Grants empower early-career cancer researchers”